Envafolimab Combined With Chemotherapy in Metastatic or Recurrent Gastric Adenocarcinoma
Clinical trial NCT05237349 · UNKNOWN
Trial details
- NCT number
- NCT05237349
- Sponsor
- Liangjun Zhu M.M.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-01
- Primary completion
- 2024-12-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.